Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4′-amino-3′-hydroxy-doxorubicin
- 1 July 1992
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (4) , 261-265
- https://doi.org/10.1007/bf00685942
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Doxorubicin-Induced Cardiac ToxicityNew England Journal of Medicine, 1991
- Anthracycline Cardiotoxicity: In vivo and in vitro Effects on Biochemical Parameters and Heart Ultrastructure of the RatOncology, 1991
- Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)Biochemical Pharmacology, 1989
- A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activityJournal of Immunological Methods, 1988
- Qualitative analysis of chromosomal evolution in a colcemid-treated chinese hamster populationTeratogenesis, Carcinogenesis, and Mutagenesis, 1988
- A simple experimental index for the evaluation of inotropic responsesJournal of Pharmacological Methods, 1987
- Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4′-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissuesBiochemical Pharmacology, 1987
- Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the ratJournal of Pharmacological Methods, 1986
- Comparative intracellular uptake of adriamycin and 4'-deoxydoxorubicin by nonsmall cell lung tumor cells in culture and its relationship to cell survivalBiochemical Pharmacology, 1986
- Absence of generation of oxygen-containing free radicals with 4′-deoxydoxorubicin, a non-cardiotoxic anthracycline drugBiochemical and Biophysical Research Communications, 1984